IAIM
ABBV icon

International Assets Investment Management’s AbbVie ABBV Stock Holding History

International Assets Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.98M Buy
19,832
+992
+5% +$213K 0.3% 58
2026
Q1 		$4.05M Buy
18,840
+136
+0.7% +$30.2K 0.28% 70
2025
Q4 		$4.27M Buy
18,704
+169
+0.9% +$38.5K 0.29% 55
2025
Q3 		$3.52M Hold
18,535
– – 0.28% 61
2025
Q2 		$3.44M Sell
18,535
-807
-4% -$150K 0.28% 62
2025
Q1 		$4.05M Sell
19,342
-1,905
-9% -$370K 0.36% 48
2024
Q4 		$3.81M Sell
21,247
-4,706,816
-100% -$865M 0.32% 50
2024
Q3 		$561K Buy
4,728,063
+4,471,806
+1,745% +$835M 1.54% 7
2024
Q2 		$3.37M Sell
256,257
-9,688
-4% -$1.6M 0.32% 41
2024
Q1 		$3.49M Sell
265,945
-1,305
-0.5% -$225K 0.36% 42
2023
Q4 		$3.23M Buy
+267,250
New +$39M 0.41% 40
2023
Q3 		– Sell
-234,596
Closed -$1.78M – 619
2023
Q2 		$1.78M Buy
234,596
+10,139
+5% +$1.49M 0.24% 86
2023
Q1 		$2.03M Sell
224,457
-186,031
-45% -$28.4M 0.29% 67
2022
Q4 		$5.61M Buy
410,488
+398,816
+3,417% +$61.2M 0.58% 31
2022
Q3 		$1.57M Buy
11,672
+1,074
+10% +$154K 0.34% 65
2022
Q2 		$1.62K Sell
10,598
-119
-1% -$18.2K 0.15% 68
2022
Q1 		$1.74M Sell
10,717
-433
-4% -$62.9K 0.31% 71
2021
Q4 		$1.51M Sell
11,150
-43,673
-80% -$5.16M 0.26% 88
2021
Q3 		$1.22M Buy
54,823
+41,418
+309% +$4.73M 0.22% 116
2021
Q2 		$1.06M Sell
13,405
-13,096
-49% -$1.47M 0.2% 122
2021
Q1 		$1.79M Buy
26,501
+12,997
+96% +$1.39M 0.16% 127
2020
Q4 		$811K Buy
13,504
+8,105
+150% +$779K 0.15% 136
2020
Q3 		$473K Sell
5,399
-585
-10% -$55.1K 0.12% 172
2020
Q2 		$587K Buy
5,984
+443
+8% +$39K 0.14% 143
2020
Q1 		$422K Buy
+5,541
New +$472K 0.13% 152

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

International Assets Investment Management's ABBV Position: Q2 2026 in Review

International Assets Investment Management increased its AbbVie (ABBV) stake by 5.3% in Q2 2026, buying an estimated $213K and bringing the position to 19,832 shares worth $4.98M. The position accounts for 0.3% of the portfolio, ranked #58.

International Assets Investment Management first reported a position in ABBV in Q1 2020 and has held it in 25 quarters since. The position peaked at $5.61M in Q4 2022. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • International Assets Investment Management held 19,832 shares of AbbVie worth $4.98M as of Q2 2026.
  • International Assets Investment Management bought 992 AbbVie shares in Q2 2026, an estimated $213K.
  • AbbVie made up 0.3% of International Assets Investment Management's portfolio in Q2 2026, its #58 holding.
  • International Assets Investment Management first reported a position in AbbVie in Q1 2020 and has held it in 25 quarters since.
  • International Assets Investment Management's AbbVie position peaked at $5.61M in Q4 2022.
  • 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.